Keating Financial Advisory Services’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$599 Sell
24
-1
-4% -$26 ﹤0.01% 2245
2026
Q2
$782 Sell
25
-4
-14% -$99 ﹤0.01% 2244
2026
Q1
$607 Buy
+29
New +$404 ﹤0.01% 2222

Other funds holding TNGX

Keating Financial Advisory Services's TNGX Position: Q3 2026 in Review

Keating Financial Advisory Services reduced its Tango Therapeutics (TNGX) stake by 4% in Q3 2026, selling an estimated $26 and leaving 24 shares worth $599. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Keating Financial Advisory Services first reported a position in TNGX in Q1 2026 and has held it in 3 quarters since. The position peaked at $782 in Q2 2026. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Keating Financial Advisory Services held 24 shares of Tango Therapeutics worth $599 as of Q3 2026.
  • Keating Financial Advisory Services sold 1 Tango Therapeutics share in Q3 2026, an estimated $26.
  • Tango Therapeutics made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q3 2026, its #2245 holding.
  • Keating Financial Advisory Services first reported a position in Tango Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Tango Therapeutics position peaked at $782 in Q2 2026.
  • 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Keating Financial Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.